Navigation Links
ESBATech's Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications
Date:4/24/2008

ESBA105 Penetrates all Segments of the Eye via Topical Eye Drops

ZURICH, Switzerland, April 24 /PRNewswire/ -- ESBATech AG, a leading developer of antibody fragment therapeutics, today announced the initiation of Phase I clinical development of the company's lead product development candidate, ESBA105, in ophthalmology. This Phase I study is designed to evaluate the safety, tolerability and pharmacokinetic profile of ESBA105, when delivered topically via eye drops in healthy volunteers. The study is being conducted as a single and repeated dose escalation study in Switzerland. ESBA105 is a single-chain antibody fragment directed against TNFa. It is being developed initially for ophthalmic indications.

In previously reported in vivo, preclinical studies, ESBA105 achieved high therapeutic concentrations in all ocular tissues, when delivered topically via eye drops. Therapeutic concentrations of ESBA105 were observed throughout the anterior (front) and the posterior (back) segments of the eye, the latter including the vitreous humor, retina and choroid.

Peter Lichtlen, M.D., Ph.D., Head of Clinical Development at ESBATech AG, commented, "ESBA105 shows an entirely novel and unique intraocular distribution pattern upon topical administration to the eye. Therapeutic levels are reached in both the aqueous and vitreous humor after only a couple of hours following initiation of treatment. Our in vivo, preclinical studies have shown that ESBA105 has a prolonged half-life of 25 hours in the vitreous. Thus, the vitreous acts as a natural depot compartment for ESBA105, allowing for highly attractive maintenance dosing regimens. TNFa is a rapidly emerging target in ophthalmology and ESBA105 has the potential to be a significant advancement in anti-inflammatory ophthalmic medicine."

Dominik Escher, Ph.D., Chief Executive Officer of ESBATech AG, added, "This is a major corporate milestone for ESBATech. After having developed a repeatable technol
'/>"/>

SOURCE ESBATech AG
Copyright©2008 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2 3

Related medicine technology :

1. Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
2. MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
3. OncoMed Chooses SynCo Bio Partners to Fill and Finish its Lead Antibody
4. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
5. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
6. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
7. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
8. Raven Announces Completion of Enrollment in the Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for the Treatment of Adenocarcinomas
9. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
10. Celltrion and CSL Announce Collaboration to Develop and Manufacture Monoclonal Antibody
11. Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013  Avanir Pharmaceuticals, Inc. (NASDAQ: ... an overview of the company at the following conferences. ... , Presentation date: Wednesday May 29, 2013 , Presentation ... Global Healthcare Conference , Presentation date: Wednesday June 5, ... A live webcast and 30-day archive ...
(Date:5/22/2013)... , May 22, 2013  Flagship Ventures, a ... on healthcare and sustainability, today announced the appointment ... a Senior Partner. In this role, Mr. Bancel ... companies. In addition to working closely ... also serves as President and Chief Executive Officer ...
(Date:5/22/2013)... -- Grifols, a global healthcare company based in ... demonstrating that a higher dose of PROLASTIN © -C ... alpha 1 protein in patients with alpha 1 ... the normal range for healthy individuals. AAT deficiency is ... the alpha 1 proteinase inhibitor (A1PI) protein can ...
Breaking Medicine Technology:Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4
... ANN ARBOR, Mich., June 19 ... change interventions with outcomes, announced a,new research ... Insomnia and Overcoming(TM) Depression online behavior,change interventions ... Aetna,s,large employer members. Together, HealthMedia and Aetna ...
... safety and effectiveness of using cloned cells alone ... ... use of a human patient,s cloned infection-fighting T cells as,the sole therapy ... Cassian Yee, M.D., an associate member of the,Clinical Research Division at Fred ...
Cached Medicine Technology:HealthMedia and Aetna to Study Online Insomnia and Depression Interventions 2HealthMedia and Aetna to Study Online Insomnia and Depression Interventions 3HealthMedia and Aetna to Study Online Insomnia and Depression Interventions 4Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation 2Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation 3
(Date:5/22/2013)... @the_USO & @SesameStreet are proud to kick-off ... the next 6 months! , Today, the ... together to show their heartfelt thanks to those who currently serve ... distribution to our servicemen and women. The group was also ... the USO as well as the success of the Sesame ...
(Date:5/22/2013)... 22, 2013 Nearly 50,000 veterans appeals ... in fiscal year 2012, with even more—54,033—expected by fiscal ... for a decision as the agency reports reduced decisions ... veterans disability appeal services. The BVA is ... , Although the BVA received 49,611 cases in FY ...
(Date:5/22/2013)... By Dennis Thompson HealthDay Reporter , , WEDNESDAY, ... migraines or back pain are more likely to attempt ... or another psychiatric condition, according to a new study. ... conditions should be aware they are at increased risk ... Veterans Affairs Serious Mental Illness Treatment Resource and Evaluation ...
(Date:5/22/2013)... Bodybuilding.com is giving back to ... 2013) Bodybuilding.com will be donating $1 from EVERY purchase made ... “We are extremely grateful for the men and women who ... DeLuca, CEO and founder of Bodybuilding.com. “It’s an honor to ... much. Hire Heroes USA is an amazing organization that supports ...
(Date:5/22/2013)... Today, Zane Benefits, Inc. published a new ... Zane Benefits, which provides comprehensive and flexible alternatives to ... defined contribution plans and health reimbursement ... in 2014 as part of the Affordable Care Act ... will become available through new state health insurance exchanges. ...
Breaking Medicine News(10 mins):Health News:The USO and Sesame Street Announce Spring Kick Off of World Tour at Biannual Care Package Service Project Event in DC 2Health News:The USO and Sesame Street Announce Spring Kick Off of World Tour at Biannual Care Package Service Project Event in DC 3Health News:The USO and Sesame Street Announce Spring Kick Off of World Tour at Biannual Care Package Service Project Event in DC 4Health News:The USO and Sesame Street Announce Spring Kick Off of World Tour at Biannual Care Package Service Project Event in DC 5Health News:Veterans Disability Appeals See Fewer Decisions in FY2012, Reports Allsup 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 3Health News:In the Spirit of Memorial Day, Bodybuilding.com is Donating a Portion of Their Sales to Hire Heroes 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3
... of Medical Records Into a User,s ... ... UNIVAL, Inc., a healthcare,company that delivers a variety of integrated ... the Microsoft,HealthVault platform. HealthVault lets consumers collect, store, and share,health ...
... A new video blog will document one woman,s fight to end the ... participants of The Diabetes Challenge, a contest hosted by the Lifestyle Center ... ... -- A new video blog will document one woman,s fight to end ...
... Breast Cancer Awareness Month. And, there,s no better time than the present ... to become more informed about how the disease could affect you, your ... ... October 23, 2008 -- Last year, over 2.3 million women were diagnosed ...
... 22 Every year in Jacksonville,nearly 600 adults ... now,their long road to recovery lacked long-term support. ... the only program,in Florida created to help people ... community reintegration., The Brain Injury Association of ...
... physician, caregiver and pet therapy awards, MILWAUKEE, ... a,top national award from the Planetree organization. Aurora ... for Kradwell School at,Planetree,s national conference in Chicago ... dedicated to a,patient-centered, holistic approach to health care. ...
... Verification Safeguards Allow Thieves to Steal, SAN ... Americans,are the victims of identity theft, and in ... theft victim Eric Drew claims that the,credit industry ... by fully automating their identity verification systems, credit,card ...
Cached Medicine News:Health News:UNIVAL(R), Inc. Becomes a Microsoft(R) HealthVault(TM) Application Provider 2Health News:Video Blog Chronicles One Woman's Fight Against Her Diabetes 2Health News:The Pink Ribbon That Could Save Your Life 2Health News:The Pink Ribbon That Could Save Your Life 3Health News:Brooks Rehabilitation Opens First Work-Based Brain Injury Rehab Program in Florida 2Health News:Aurora Health Care's Kradwell School Receives National Planetree Award 2Health News:Aurora Health Care's Kradwell School Receives National Planetree Award 3Health News:Aurora Health Care's Kradwell School Receives National Planetree Award 4Health News:Aurora Health Care's Kradwell School Receives National Planetree Award 5Health News:Credit Card Companies Accomplices in Millions of Identity Theft Cases Alleges Eric Drew 2
... The Acceava Mononucleosis test provides ... Mononucleosis with a simple procedure that ... Side-by-side evaluations with competitive products will ... These attributes enable you to deliver ...
... for the visual, qualitative detection ... infectious mononucleosis in human serum, ... This test is intended as ... of infectious mononucleosis in patients ...
The NOW® Flu B test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results an...
... Absorbable Hemostat is a purified and lyophilized ... a sponge-like pad, is lightly cross-linked, sterile, ... an inherent property of collagen, is largely ... this protein. The helical structure of native ...
Medicine Products: